Companies
Atlantic Sapphire
the world's largest land-based salmon farm in Homestead, FL (founded 2010), Phase-1 capacity 7,500–8,500 t/yr; Q1 2026 harvest 1,504 t HOG (+27% QoQ) at USD 9.32/kg — but the company entered a restructuring agreement in May 2026 after a $10M bridge loan (12% interest,…
- Country
- United States
- Ticker
- OSE:ASA
Recirculating aquaculture (RAS)
Land-based / zero-wild-contact
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| livestock-aqua | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaefsamoa-china
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | USD 10 million bridge loan secured in March 2026, with further liquidity requirements of USD 25-30 million to reach EBITDA breakeven | stockanalysis.com · marketscreener.com |
| Capacity | Phase 1 annual harvest capacity of approximately 7,500-8,500 tons HOG, with a Phase 2 expansion targeting 25,000 tons total capacity and a 2031 target of 220,000 tons | inderes.fi · marketscreener.com · salmonbusiness.com |
| Certification | Aquaculture Stewardship Council (ASC) certified, American Heart Association Heart-Check certified, and Friend of the Sea certified | atlanticsapphire.com · undercurrentnews.com |
| Regulatory approval | Holds the requisite permits and patents for its Bluehouse facility in Homestead, Florida | inderes.fi · marketscreener.com |
| Production site | Homestead, Florida (US Bluehouse) and Hvide Sande, Denmark (innovation center operated 2011-2021) | atlanticsapphire.com · marketscreener.com · salmonbusiness.com |
| Headcount | 201 employees (as of 2025 reporting) medium confidence | atlanticsapphire.com · uk.marketscreener.com |
| Revenue | USD 43.29 million for the 2025 fiscal year | stockanalysis.com · marketscreener.com |
Independent sources: inderes.fi · marketscreener.com · salmonbusiness.com · stockanalysis.com · uk.marketscreener.com · undercurrentnews.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Aquaculture & fish farming | livestock-aqua | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.